TY  - JOUR
AU  - Martínez-Santana, Virginia
AU  - González-Sarmiento, E
AU  - Calleja-Hernández, MA
AU  - Sánchez-Sánchez, T
PY  - 2013
DO  - 10.2147/PPA.S47453
SN  - 1177-889X (Online)
UR  - http://hdl.handle.net/10668/1401
T2  - Patient preference and adherence
AB  - BACKGROUNDPersistence of anti-tumor necrosis factor (TNF) therapy in rheumatoid arthritis (RA) is an overall marker of treatment success.OBJECTIVETo assess the survival of anti-TNF treatment and to define the potential predictors of drug...
LA  - en
PB  - Dove Medical Press
KW  - Rheumatoid arthritis
KW  - Biologic agents
KW  - Tumor necrosis factor
KW  - Drug administration schedule
KW  - Artritis Reumatoide
KW  - Receptores del Factor de Necrosis Tumoral
KW  - Agentes Biológicos
KW  - Esquema de Medicación
KW  - Antirreumáticos
KW  - Medical Subject Headings::Diseases::Musculoskeletal Diseases::Rheumatic Diseases::Arthritis, Rheumatoid
KW  - Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, Immunologic::Receptors, Cytokine::Receptors, Tumor Necrosis Factor
KW  - Medical Subject Headings::Chemicals and Drugs::Complex Mixtures::Biological Agents
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Schedule
KW  - Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antirheumatic Agents
TI  - Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis.
TY  - research article
ER  -